CLINICAL PHARMACOLOGY SHARED RESOURCE

临床药理学共享资源

• 批准号: 7944619
• 负责人: LIONEL David LEWIS
• 金额: $ 15.14万
• 依托单位: DARTMOUTH COLLEGE
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-04-21 至 2013-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7944619
• 关键词: Aliquot; Animals; Antineoplastic Agents; Applications Grants; Arts; Back; Bar Codes; Biological; Biological Assay; Biological Process; Budgets; CYP2C9 gene; CYP2D6 gene; Calcium; Cancer Center; Cancer Center Support Grant; Cells; Clinical; Clinical Chemoprevention; Clinical Oncology; Clinical Pharmacology; Clinical Protocols; Clinical Research; Clinical Trials; Computers; Concentration measurement; Consultations; Data; Data Analyses; Databases; Detection; Development; Documentation; Drug Kinetics; Enrollment; Epidemiologic Studies; Epidemiology; Etoposide; Evaluation; Evaluation Studies; Fluorescence; Folate; Funding; Future; Genetic Polymorphism; Hemoglobin; High Pressure Liquid Chromatography; In Vitro; Individual; Investigational Drugs; Kynurenine; Laboratory Research; Leadership; Learning; Liquid substance; Mails; Malignant Neoplasms; Measurement; Measures; Methodology; Modeling; Molecular Biology; Monitor; Norris Cotton Cancer Center; Nursing Research; Oncology Group; Patient Care; Patients; Performance; Peripheral Blood Mononuclear Cell; Pharmaceutical Preparations; Pharmaceutical Services; Pharmacists; Pharmacodynamics; Pharmacogenetics; Pharmacogenomics; Pharmacology Shared Resource; Pharmacotherapy; Pharmacy facility; Phase; Pilot Projects; Plasma; Pre-Clinical Model; Printing; Process; Protocols documentation; Reader; Research; Research Design; Research Personnel; Resource Sharing; Resources; Saliva; Sampling; Scanning; Services; Source; Specimen; System; Technology; Testing; Therapeutic Studies; Tissue Sample; Tissues; Tryptophan; Tumor Tissue; Urine; Work; Zebra; anticancer research; biobank; cost; design; docetaxel; in vivo; member; novel; oncology; pre-clinical; preclinical study; repository; research study; tumor; volunteer

The primary function of the Clinical Pharmacology Shared Resource (CPSR) is to support NCCC investigators in the design, performance, data analysis, and interpretation of clinical pharmacology objectives in preclinical (ex-vivo and in vivo), clinical, chemoprevention, and epidemiological studies, at as low a cost as possible. The CPSR has modified its staffing since the last submission such that it now consists of one clinical pharmacologist, one research assistant and a part of a second research assistant, a research nursing resource, and a part of a research pharmacist. The major CPSR services include: 1) Central processing for biological tissue samples (e.g. cells/tumor tissue/plasma/saliva/urine) and cell samples obtained as part of approved clinical and epidemiological protocols: these services include, but are not limited to, sampleprocessing (including processing peripheral blood mononuclear cells), logging and storage, aliquoting, and mail-outs; 2) (a) Development of novel drug assays (when such assays are not routinely available) using either HPLC (UV/Fluorescence detection) or LC-MS/MS methodology, (b) Performance of drugconcentration measurements in biological fluids and tissues for preclinical and clinical oncology studies; 3) (a) Consultation concerning study design and pharmacokinetic and pharmacodynamic hypothesis-testing in preclinical and clinical studies, (b) Pharmacokinetic and pharmacodynamic data analysis and modeling from pre-clinical and clinical studies; 4) Phase-l and proof-of-principle study research nursing support services; 5) Pharmacogenomic (PGx) assays and expertise applied to cancer drug research; and 6) Research Pharmacy Service for oncology drug research with commercially available and investigational new drugs. The CPSR currently provides 13 NCCC investigators with services valued at $118,881 in chargebacks for FY 2007. NCCC members represent 76% of the total number of investigators using this facility at Dartmouth, and their usage constitutes 87% of total CPSR usage. The total chargebacks for this core were $130,161 during FY2007, and the total operating budget was $397,951, requiring $267,789 in non-chargeback subvention, which is derived from a combination of the NCCC CCSG and chargebacks to other sponsored projects. This shared resource is requesting a budget of $109,722 from the NCCC CCSG for the first year of this competitive renewal (2008-09), representing a level comparable to the current year's support, which will provide 39% of its non-chargeback subvention needs, while the majority of costs are recovered through chargebacks and other institutional support. This core grant budget and the other subvention sources primarily underwrite a portion of the chargeback costs to individual NCCC investigators and provide administrative support for oversight of this shared resource.

临床药理学共享资源（CPSR）的主要功能是支持NCCC